Studieoverzicht
|
BOOG nr.: |
Status: ( Open )
|
Indication: ( Advanced/metastatic )
|
Subindication: |
Menopausal status: |
| 2021-03 EMBER-3 | Open | Advanced/metastatic | HER2- HR+ | Both pre- and postmenopausal | ||||||||||||||
| 2021-01 SEQUEL-Breast | Open | Advanced/metastatic | HER2- HR+ | Both pre- and postmenopausal | ||||||||||||||
| 2019-01 TIBET | Open | Advanced/metastatic | HER2- HR+ | Both pre- and postmenopausal |